Displaying 361 - 380 of 2213
Dr. Brunoni's research focuses on developing innovative therapeutic strategies using transcranial direct current stimulation, transcranial magnetic stimulation, and other neuromodulation techniques for treating major depressive disorder, bipolar disorder, OCD, schizophrenia, and post-COVID cognitive symptoms.
The Cardiovascular Pharmacotherapy Research Lab integrates molecular epidemiology, clinical pharmacology, clinical trials and population health science to identify new pathways and therapeutic strategies for the prevention of heart failure. Our team conducts cross-disciplinary, mechanism-focused clinical research to translate biologic discoveries into interventions with meaningful public health impact.
Research lab at UT Southwestern for Mohan Krishnan, Ph.D.
Our laboratory is interested in studying the intersection between lung cancer and immunology. We are currently focused on co-opting innate immune signaling pathways and tumor-associated T cell populations to target diverse subsets of lung cancer.
The Sankary Neuroethics Lab at UT Southwestern explores the ethical dimensions of neuroscience and neurosurgical innovation.
Neuron-cancer interactions that promote tumor growth and disrupt neural circuits.
The central goal of Dr. Asch's research is to uncover the mechanistic underpinnings of how stress and trauma affect brain function, with a particular emphasis on how these experiences shape mental health outcomes with the aim to contribute to the development of novel interventions designed to mitigate the harmful effects of stress and trauma, foster resilience, and ultimately improve overall
health and well-being.
The Bartelt Lab is focused on understanding the epigenetic basis of cerebellar neurodegenerative disorders to develop holistic gene therapies. Using single-cell and spatial sequencing approaches, we profile healthy and diseased states to identify gene regulatory mechanisms in disease and utilize functional genomic tools to advance therapeutic approaches.
Medical Artificial Intelligence and Automation
The Sweat lab studies how perturbations in cardiac gene expression result in arrhythmias, with a focus on atrial fibrillation. We apply single-cell multiomics and epigenetics approaches to gain insight into mechanisms of arrhythmia and potential new treatment approaches231`
The Voice Behavior and Rehabilitation Laboratory, led by Dr. Laura Toles, performs research in the field of Otolaryngology with focus on individual differences, personality and voice, phonotrauma, vocal behavior, and improving therapeutic outcomes.
Shi Lab focuses on developing AI systems for healthcare, with an emphasis on large language models, agentic AI, clinical informatics, personalized medicine, tool/retrieval-augmented learning, reasoning, and data-centric AI.
The Kelesidis Lab studies the cross between viral infections and mechanisms of associated end organ damage with a goal to develop novel therapeutic treatments.
The Schaffert Lab advances understanding of cognitive decline and recovery mechanisms by investigating (1) idiopathic normal pressure hydrocephalus, focusing on cognitive, neurobiological, and pathophysiological processes that shape impairment and postoperative recovery, and (2) long-term cognitive impairment and dementia following traumatic brain injury, with emphasis on identifying factors associated with persistent deficits, accelerated cognitive aging, and later-life neurodegenerative diagnoses.
Developing novel interventions for psychiatric disorders, personalizing the use of currently available treatments, and bringing these scientific discoveries to clinical practice.
The Lieber Lab studies life after liver transplantation — focusing on survivorship experiences of patients and their caregivers. Our research seeks to understand what it means to go through this life-saving and life-changing surgery. By listening to the voices of those who have lived it, we aim to improve transplant care, guide future programs, and help people achieve better long-term health and quality of life after transplant.
The Advanced Integrative Molecular Probe Collaboration's mission is to develop new imaging agents in a multidisciplinary approach to monitor, understand and cure disease at an early stage.
Our goal is to understand and exploit the immunogenic properties of tumor irradiation in integrating it with immunotherapy to improve cancer patient outcome.
Our mission is to innovate, develop, and apply biomedical technology to empower cancer research.
Our mission is to improve the care of breast cancer patients through cutting-edge translational research at the interface of clinical oncology, cancer biology, molecular genetics, and translational genomics.
